Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
State Council Issues Document for Major Healthcare Reform Tasks in 2016
General Office of the State Council issued a new document, Major Tasks of 2016 for Deepening Pharmaceutical and Health System Reform, on April 26.... (4/26/2016)
   
China's Life Science Innovative Development Policies (5/3/2016)
China's Coming Crackdown on Healthcare Corruption (4/29/2016)
In China's Tougher Drug Market, Minnows Open Back Door for 'Big Pharma' (4/29/2016)
Kendall Squared - Chinese Biopharma Companies Set down Roots in Boston Area (4/14/2016)
Compliance in China: Ongoing Regulatory and Operational Challenges (4/8/2016)
Advice for Biopharmas in China? Mind the Gap (4/8/2016)
'Chindia' Drug Substance Market Not To Be Discounted (4/7/2016)
How Patient Do Chinese Patients Need To Be (for Innovative Drugs)? (3/31/2016)
R&G: China FDA Launches a New Classification System for Registration of Chemical Drugs (3/29/2016)
WSJ: Chinese Market Offers New Life to Many Drugs (3/29/2016)
China's Changing Clinical Trial Environment (3/29/2016)
Both NDRC and SAIC Shed Light on the Antitrust Scrutiny on Pharmaceutical Industries (3/29/2016)
One Startup's Journey To Improve Healthcare Access In China (3/24/2016)
Commercial Models In China's Pharma Sector Must Change (3/24/2016)
China Pushes Pharmaceutical Sector Reform from the Supply Side (3/21/2016)
Zai Lab In-licenses BMS’s Failed Liver ...  (5/5/2016)
CSPC Pharma Outlicenses Complex Generic ...  (5/4/2016)
CFDA Releases Interim Dossier Requiremen...  (5/4/2016)
Nicholas Hall Reports 7% Growth for Chin...  (5/4/2016)
CDE Announces Two Anticancers Granted Pr...  (5/4/2016)
Where Will the Chinese Government Spend ...  (5/3/2016)
CFDA Issues Document to Boost Regulation...  (5/3/2016)
Military Hospitals to Introduce Essentia...  (5/3/2016)
New Study Finds Sharp Rise of Obesity Am...  (5/3/2016)
Hengrui Medicine, MD Anderson Form Partn...  (5/3/2016)
AstraZeneca Saw Slower China Business Gr...  (5/3/2016)
GSK's Drug Sales in China Tumbled 28% in...  (5/3/2016)
USTR Singles Out China's Pharma IP Flaws...  (5/3/2016)
IMS Health Holdings and Quintiles to Com...  (5/3/2016)
Financial-related Local Company News in ...  (5/3/2016)
IMS Health Holdings and Quintiles to Combine
Pfizer Abandons Plans to Take Over Allergan Citing New U...
Top 15 Pharma MNCs Experienced Stagnant Performance in 2...
Korean Authorities Raid Novartis Offices Over Bribery Al...
GSK Acquires BMS's HIV Treatments Worth Up To GBP 974.6M...
Nicholas Hall Reports 7% Growth for Chinese OTC VMS Market in 2...
IMS: Chinese Retail Pharmacy Sales Up 9.2% in MAT Q4/2015
Data Snapshot - Overview of Chinese Blood Product Market
Hospital Antibiotic Consumption Growth Resumed in 2015
Data Snapshot: Chinese Anticancer Market Overview 2010-2015E
Zai Lab In-licenses BMS’s Failed Liver Cancer Drug Brivanib...
CSPC Pharma Outlicenses Complex Generic Anticancer to Watson...
Hengrui Medicine, MD Anderson Form Partnership to Advance Im...
AstraZeneca Saw Slower China Business Growth in Q1/2016
GSK's Drug Sales in China Tumbled 28% in Q1/2016 Due to Rest...
CFDA Releases Interim Dossier Requirements under the New...
CDE Announces Two Anticancers Granted Priority Review
CFDA Issues Document to Boost Regulation of Pharma Whole...
NHFPC and CFDA Forms National Stem Cell Clinical Researc...
CFDA Issues Interim Rules for Coordinated Use of Drug In...
USTR Singles Out China's Pharma IP Flaws in 2016 Special 301...
USTR releases "Special 301" Report on IP R...
More Details Surface for the Recent GSK Trade Secret Theft C...
WIPO Says China's Innovation Capacity Improving As the Count...
Proposal for Pharmacist Legislation Ready for NPC Submission...
UK Regenerative Medicine Supplier Expands to China Thru ...
FDA Issues More Warnings Against Chinese API Producers
Dong-A ST Signs Exclusive Deal with Suzhou Sino for Teri...
French Inspectors Uncover Irregularities of Chinese Crud...
Zhejiang Jiuzhou Enters API Supply Agreement with Novart...
BeiGene Presents Positive Clinical Data for RAF Dimer In...
Chi-Med Begins Phase I Trial of HMPL-689 in Australia
The Rise of Innovation in China's Life Science Sector
Chi-Med Initiates Sulfatinib Phase III Study in Pancreat...
Ambrx and Zhejiang Medicine initiated ARX788 Phase I Tri...
Where Will the Chinese Government Spend Its CNY 1.2T Hea...
Military Hospitals to Introduce Essential Drug System
New Study Finds Sharp Rise of Obesity Among Rural Teens
NHFPC Issues Tender Announcement for Designated Manufact...
MOHRSS Responds to Media Questions for BMI Payment Refor...
Financial-related Local Company News in Brief
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Upcoming Event: Pharma Business Development Course
NHFPC Vice Minister Meets Sanofi Pasteur President
Upcoming Event: Pharma Business Development Course
Upcoming Event: Pharma China Seminar 2016 in NJ on April...
Upcoming Event: Pharma China Seminar 2016 in NJ on April...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links